Abstract:The organic solvent solution immersion method was often used to achieve the loading of the drugs into mesoporous silica, but the drugs that have loaded into the pores of the mesoporous silica would inevitable migrate from the inside to the external surface or near the outside surface during the process of drying. Hence, it often leads to the pores of mesoporous materials not be fully utilized, and results in a low drug loading efficiency and a fast releasing rate.The purpose of this study was to develop a novel drug loading strategy to avoid soluble component migration during the process of drying, then, to prepare poorly water-soluble drug mesoporous silica microparticles with higher drug loading efficiency and longer sustained-release time.Ibuprofen was used as model drug. The microparticles were prepared by a novel method based on mesoporous silica and supercritical fluid (SCF) technique. The drug-loaded mesoporous silica microparticles prepared by SCF technique were analyzed by thermogravimetric analysis (TGA), N2 adsorption/desorption, scanning electron microscopy (SEM), powder X-ray diffraction (XRD) and differential scanning calorimetry (DSC). In vitro releasing study was used to evaluate the sustained-release effect of the drug-loaded microparticles.By virtue of the high diffusibility and the high dissolving capacity of the supercritical carbon dioxide (SCF-CO2), the poorly water-soluble drugs, ibuprofen, entered the pores of the mesoporous silica. The amount and the depth of ibuprofen entered the pores of the mesoporous silica by SCF technique were both larger than those by the solution immersion method. It was found that ibuprofen loaded into the mesoporous silica by SCF technique was amorphous and the largest amount of the ibuprofen loaded into the mesoporous silica by SCF technique could reach 386 mg/g (w/w, ibuprofen/SiO2), it was more than that by the solution immersion method. In vitro releasing study showed that the sustained-release effect of ibuprofen in the samples prepared by SCF technique was 50% in 15 min and 90% in 60 min. It was longer than that prepared by the solution immersion method.Present study showed that sustained-release poorly water-soluble drug mesoporous silica microparticle based on SCF technique has twofold advantages. One is the larger drug loading amount in internal pores of the mesoporous silica, the other is the longer drug releasing time.

Chemical surface modification of mesoporous SiO 2 -based membranes for fine-tuning of drug loading and release properties

Mesoporous Silica-Based Membranes in Transdermal Drug Delivery: The Role of Drug Loss in the Skin

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

Influence of pore size and surface area of mesoporous silica materilas (MCM-41 and KIT-6) on the drug loading and release

Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery

Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery

Drug Encapsulation and Release by Mesoporous Silica Nanoparticles: the Effect of Surface Functional Groups

Effect of Surface Functionalization and Pore Structure Type on the Release Performance of Mesoporous Silica Nanoparticles

Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.

Fabrication of High Surface Area Mesoporous Silicon Via Magnesiothermic Reduction for Drug Delivery

Designing of a new transdermal antibiotic delivery polymeric membrane modified by functionalized SBA-15 mesoporous filler

Mesoporous Silica Particles as Drug Delivery Systems—The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes

A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.

Successfully Tailoring the Pore Size of Mesoporous Silica Nanoparticles: Exploitation of Delivery Systems for Poorly Water-Soluble Drugs.

Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release

Silica-based mesoporous nanoparticles for controlled drug delivery

Functionalized mesoporous silica particles for application in drug delivery system.

Surface Modification of a Polylactic Acid Nanofiber Membrane by Zeolitic Imidazolate Framework-8 from Secondary Growth for Drug Delivery

Direct Surface Grafting of Mesoporous Silica Nanoparticles with Phospholipid Choline-Containing Copolymers Through Chain Transfer Free Radical Polymerization and Their Controlled Drug Delivery

Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.

Microfluidic templated mesoporous silicon-solid lipid microcomposites for sustained drug delivery.